RxDoctor Payments Data

Carl Flor

Family Medicine · Virginia Beach, VANPI 1154432375

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 25.3% of the total. Reporting peaked in 2019 at $580 and has fallen 62.6% since, to $217 in 2022.

$1,778in general payments, 2019–2025

Across 115 payments — averaging $15.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$449
  • Novo Nordisk$273
  • Boehringer Ingelheim$172
  • Pfizer$146
  • Lilly USA, LLC$98
  • Merck$78
  • plus $562 from 15 others

What the payments were for

  • Food & beverage$1,76499%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,778 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia →

Other family medicine in Virginia Beach

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →